Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-006328

President and CEO sold 43,168 shares at $7.82 ($337,574)

  • President and CEO acquired 994 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanjiv · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-31 Grant or award : show line 1 in the form +994 $2.99 $2,972 704,209 D
2026-01-06 Sale : show line 2 in the form −43,168 $7.82 $337,574 661,041 D
Open-market sales · 43,168 sh · avg $7.82 · $337,574
Loading xslF345X05/ownership.xml…